BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 15068900)

  • 1. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric DNA quantification in immunophenotyped cells as a sensitive method for determination of aneuploid multiple myeloma cells in peripheral blood stem cell harvests and bone marrow after therapy.
    Nowak R; Oelschlägel U; Range U; Bergmann S; Bornhäuser M; Hölig C; Schuler U; Krebs U; Günther H; Kroschinsky F; Ehninger G
    Bone Marrow Transplant; 1999 May; 23(9):895-900. PubMed ID: 10338044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma cells in peripheral blood stem cell harvests from patients with multiple myeloma are predominantly polyclonal.
    Pope B; Brown R; Gibson J; Joshua D
    Bone Marrow Transplant; 1997 Aug; 20(3):205-10. PubMed ID: 9257888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific aneuploidy not detected in CD19+ B-lymphoid cells from myeloma patients in a multidimensional flow cytometric analysis.
    McSweeney PA; Wells DA; Shults KE; Nash RA; Bensinger WI; Buckner CD; Loken MR
    Blood; 1996 Jul; 88(2):622-32. PubMed ID: 8695810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membrane CD22 defines circulating myeloma-related cells as mature or later B cells.
    Perfetti V; Vignarelli MC; Bellotti V; Glennie MJ; Zorzoli I; Ubbiali P; Obici L; Massa M; Ippoliti G; Ascari E; Merlini G
    Lab Invest; 1997 Oct; 77(4):333-44. PubMed ID: 9354768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease.
    Pilarski LM; Giannakopoulos NV; Szczepek AJ; Masellis AM; Mant MJ; Belch AR
    Clin Cancer Res; 2000 Feb; 6(2):585-96. PubMed ID: 10690543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
    Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
    Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of receptor activator of nuclear factor kappaB ligand on bone marrow plasma cells correlates with osteolytic bone disease in patients with multiple myeloma.
    Heider U; Langelotz C; Jakob C; Zavrski I; Fleissner C; Eucker J; Possinger K; Hofbauer LC; Sezer O
    Clin Cancer Res; 2003 Apr; 9(4):1436-40. PubMed ID: 12684416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation.
    Waddick KG; Uckun FM
    Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significance.
    Almeida J; Orfao A; Mateo G; Ocqueteau M; García-Sanz R; Moro MJ; Hernandez J; Ortega F; Borrego D; Barez A; Mejido M; San Miguel JF
    Pathol Biol (Paris); 1999 Feb; 47(2):119-27. PubMed ID: 10192879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
    Lin P; Owens R; Tricot G; Wilson CS
    Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
    Kim D; Park CY; Medeiros BC; Weissman IL
    Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of myeloma cells in the peripheral blood by flow cytometry.
    Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
    Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of multiple myeloma cells using multicolor immunofluorescence and flow cytometry].
    Tousková M; Maisnar V; Krejsek J; Kopecký O
    Vnitr Lek; 1999 Dec; 45(12):708-12. PubMed ID: 10951845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multiparametric approach for analysis of cytoplasmic immunoglobulin light chains by flow cytometry.
    Chang CC; Schur BC; Kampalath B; Lindholm P; Becker CG; Vesole DH
    Mod Pathol; 2001 Oct; 14(10):1015-21. PubMed ID: 11598172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric immunophenotyping analysis of patterns of antigen expression in non-Hodgkin's B cell lymphoma in samples obtained from different anatomic sites.
    Gervasi F; Lo Verso R; Giambanco C; Cardinale G; Tomaselli C; Pagnucco G
    Ann N Y Acad Sci; 2004 Dec; 1028():457-62. PubMed ID: 15650271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD34(+) and CD34(+)CD38(-) hematopoietic progenitors in sickle cell disease differ phenotypically and functionally from normal and suggest distinct subpopulations that generate F cells.
    Luck L; Zeng L; Hiti AL; Weinberg KI; Malik P
    Exp Hematol; 2004 May; 32(5):483-93. PubMed ID: 15145217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.